Skip to main content
Screener/Healthcare/Biotechnology

NGEN — NervGen Pharma Corp. Common stock

NASDAQ
$2.14-1.54 (-41.85%)
Micro CapPenny StockUnder $5Healthcare
$3.51
$6.30
$2.02
$2.25
EPS (TTM)$-0.59
P/E Ratio-8.54
Dividend Yield—
Market Cap$294.6M
Volume10.48M
Prev Close$3.68
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$1.7M$-0.02——
Q4 '25$0-$31.7M$-0.44——
Q3 '25$0-$3.0M$-0.04——
Q2 '25$0-$6.7M$-0.09——
Q1 '25$0-$2.7M$-0.04——
Q4 '24$0-$6.0M$-0.09——
Q3 '24$0-$3.9M$-0.06——
Q2 '24$0-$5.7M$-0.08——
Get Your Daily Market Recap
NGEN Stock Price, Chart & Analysis